ClearPoint Neuro (CLPT) Short Interest Ratio & Short Volume $12.46 -0.71 (-5.39%) Closing price 04:00 PM EasternExtended Trading$12.46 -0.01 (-0.04%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ClearPoint Neuro Short Interest DataClearPoint Neuro (CLPT) has a short interest of 744,900 shares, representing 2.88% of the float (the number of shares available for trading by the public). This marks a 2.77% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 208,999 shares to cover all short positions.Current Short Interest744,900 sharesPrevious Short Interest724,800 sharesChange Vs. Previous Month+2.77%Dollar Volume Sold Short$9.53 millionShort Interest Ratio3.2 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares27,632,000 sharesShort Percent of Float2.88%Today's Trading Volume167,855 sharesAverage Trading Volume208,999 sharesToday's Volume Vs. Average80% Short Selling ClearPoint Neuro? Sign up to receive the latest short interest report for ClearPoint Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLPT Short Interest Over TimeCLPT Days to Cover Over TimeCLPT Percentage of Float Shorted Over Time Remove Ads ClearPoint Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025744,900 shares $9.53 million +2.8%2.9%3.2 $12.80 2/28/2025724,800 shares $10.52 million +14.0%2.8%2.9 $14.52 2/15/2025635,700 shares $11.65 million -2.7%2.5%3 $18.32 1/31/2025653,400 shares $11.41 million -22.1%N/A2.8 $17.46 1/15/2025838,600 shares $12.67 million +13.5%N/A3.6 $15.11 12/31/2024739,200 shares $11.37 million -0.7%N/A3.1 $15.38 12/15/2024744,200 shares $11.40 million +1.1%N/A3.3 $15.33 11/30/2024736,200 shares $9.11 million -3.1%N/A3.3 $12.37 11/15/2024759,900 shares $8.31 million +10.5%N/A3.6 $10.93 10/31/2024687,600 shares $8.52 million -3.5%N/A3.3 $12.39 Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024712,200 shares $8.57 million +15.2%N/A3.6 $12.04 9/30/2024618,500 shares $6.93 million -13.8%N/A3.4 $11.21 9/15/2024717,800 shares $9.04 million +1.2%N/A2.9 $12.59 8/31/2024709,400 shares $9.21 million -11.3%N/A3 $12.98 8/15/2024799,700 shares $8.67 million -0.7%N/A3.4 $10.84 7/31/2024805,400 shares $5.77 million -5.9%N/A3.6 $7.16 7/15/2024855,900 shares $6.44 million -37.5%N/A4.1 $7.52 6/30/20241,370,000 shares $7.38 million +9.6%N/A6.7 $5.39 6/15/20241,250,000 shares $6.76 million +4.2%N/A9.1 $5.41 5/31/20241,200,000 shares $6.52 million -6.3%N/A8.3 $5.43 5/15/20241,280,000 shares $8.19 million -5.9%N/A7.8 $6.40 4/30/20241,360,000 shares $7.38 million +10.6%N/A8.7 $5.43 4/15/20241,230,000 shares $6.90 million -3.9%N/A8.2 $5.61 3/31/20241,280,000 shares $8.70 million -8.6%N/A8.4 $6.80 3/15/20241,400,000 shares $10.01 million +0.7%N/A9 $7.15 2/29/20241,390,000 shares $8.88 million -2.8%N/A10.3 $6.39 2/15/20241,430,000 shares $10.65 million +3.6%N/A14.4 $7.45 1/31/20241,380,000 shares $9.60 million +3.8%N/A13.1 $6.96 1/15/20241,330,000 shares $9.54 million No ChangeN/A12.5 $7.17 12/31/20231,330,000 shares $9.03 million -8.3%N/A13.2 $6.79 12/15/20231,450,000 shares $9.03 million -0.7%N/A15.3 $6.23 11/30/20231,460,000 shares $8.41 million +0.7%N/A15.7 $5.76 11/15/20231,450,000 shares $7.16 million +0.7%N/A15.7 $4.94 10/31/20231,440,000 shares $7.92 million No ChangeN/A15.8 $5.50 10/15/20231,440,000 shares $6.67 million +13.4%N/A14.2 $4.63 9/30/20231,270,000 shares $6.36 million -1.6%N/A12.9 $5.01 9/15/20231,290,000 shares $6.63 million +3.2%N/A12.8 $5.14 8/31/20231,250,000 shares $7.26 million +10.6%N/A7.9 $5.81 8/15/20231,130,000 shares $6.78 million No ChangeN/A6 $6.00 7/31/20231,130,000 shares $7.76 million -4.2%N/A6.3 $6.87Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 7/15/20231,180,000 shares $7.76 million +6.3%N/A7 $6.58 6/30/20231,110,000 shares $8.04 million +53.9%N/A6.5 $7.24 6/15/2023721,100 shares $5.02 million +0.6%N/A4.3 $6.96 5/31/2023716,700 shares $5.52 million -1.8%N/A6.8 $7.70 5/15/2023729,700 shares $6.54 million +2.5%N/A9.7 $8.96 4/30/2023712,200 shares $7.49 million -6.4%N/A10.1 $10.52 4/15/2023760,700 shares $8.04 million +1.1%N/A10.3 $10.57 3/31/2023752,600 shares $6.35 million +6.6%N/A10.6 $8.44 3/15/2023706,000 shares $5.37 million -2.1%N/A9.9 $7.61 2/28/2023720,900 shares $6.11 million +0.5%N/A10.3 $8.48 2/15/2023717,000 shares $6.52 million -2.2%N/A10.3 $9.10 1/31/2023733,200 shares $6.97 million -5.7%N/A9.6 $9.51 1/15/2023777,600 shares $8.27 million -1.3%N/A9.9 $10.63 12/30/2022788,100 shares $6.68 million -1.3%N/A9.5 $8.47 12/15/2022798,600 shares $6.57 million +1.1%N/A9.3 $8.23 11/30/2022790,100 shares $7.45 million -3.3%N/A8.6 $9.43 11/15/2022816,700 shares $8.26 million -2.0%N/A8.6 $10.11 10/31/2022833,200 shares $8.34 million -3.4%N/A7.5 $10.01 10/15/2022862,300 shares $8.31 million -6.0%N/A7.4 $9.64 9/30/2022917,100 shares $9.50 million -1.9%N/A7.7 $10.36 9/15/2022934,400 shares $11.07 million +0.5%N/A5.5 $11.85 8/31/2022930,200 shares $11.97 million -12.3%N/A5.3 $12.87 8/15/20221,060,000 shares $16.98 million -15.2%N/A5.5 $16.02 7/31/20221,250,000 shares $17.71 million -3.1%6.6%6 $14.17 7/15/20221,290,000 shares $16.43 million -3.7%7.0%5.8 $12.74 6/30/20221,340,000 shares $17.49 million -28.0%7.2%5.7 $13.05 6/15/20221,860,000 shares $19.21 million +2.2%10.0%8 $10.33 5/31/20221,820,000 shares $19.95 million +0.6%9.8%9.2 $10.96 5/15/20221,810,000 shares $15.48 million +24.8%9.7%8.6 $8.55 4/30/20221,450,000 shares $12.43 million +2.8%7.8%7.2 $8.57 4/15/20221,410,000 shares $16.07 million +3.7%7.6%6.3 $11.40 3/31/20221,360,000 shares $14.16 million No Change7.3%6 $10.41 3/15/20221,360,000 shares $10.93 million +3.0%7.3%5.7 $8.04 2/28/20221,320,000 shares $11.55 million +20.0%7.1%5.1 $8.75 2/15/20221,100,000 shares $9.19 million +14.6%5.9%4.1 $8.35 1/31/2022959,600 shares $8.47 million +21.9%5.2%3.3 $8.83 1/15/2022787,400 shares $7.76 million +8.9%N/A2.8 $9.85 12/31/2021723,000 shares $8.11 million -7.4%3.8%2.7 $11.22 12/15/2021780,400 shares $9.08 million +18.4%4.1%3.1 $11.64 11/30/2021659,300 shares $9.05 million +1.0%3.5%2.9 $13.73 11/15/2021653,000 shares $10.39 million -15.1%3.5%3 $15.91 10/29/2021769,300 shares $12.87 million -4.2%4.4%3.5 $16.73 10/15/2021803,000 shares $14.42 million -6.6%4.6%3.4 $17.96 9/30/2021859,600 shares $15.26 million -6.6%4.9%3.3 $17.75 9/15/2021920,600 shares $16.55 million +7.4%5.2%2.7 $17.98 8/31/2021857,400 shares $16.18 million -38.8%5.0%2.4 $18.87 8/13/20211,400,000 shares $24.78 million +10.2%8.1%3.6 $17.70 7/30/20211,270,000 shares $28.23 million +11.4%7.9%3.4 $22.23 7/15/20211,140,000 shares $19.07 million +38.2%7.1%3.2 $16.73 6/30/2021825,000 shares $15.75 million +70.4%5.1%2.2 $19.09Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 6/15/2021484,100 shares $9.35 million -13.0%3.0%1.4 $19.32 5/28/2021556,200 shares $10.25 million +13.6%3.3%1.5 $18.42 5/14/2021489,600 shares $8.54 million -5.6%2.9%1.1 $17.45 4/30/2021518,400 shares $10.99 million +28.8%3.1%1.1 $21.20 4/15/2021402,600 shares $8.37 million +23.9%2.4%0.8 $20.80 3/31/2021324,900 shares $6.36 million +3.6%2.0%0.7 $19.58 3/15/2021313,600 shares $6.35 million +63.0%1.9%0.7 $20.25 2/26/2021192,400 shares $4.16 million -2.9%1.2%0.5 $21.64 2/12/2021198,100 shares $5.04 million -45.1%1.4%0.6 $25.44 1/29/2021360,800 shares $8.76 million +31.3%2.8%1.5 $24.27 1/15/2021274,800 shares $4.33 million No Change2.1%1.2 $15.76 CLPT Short Interest - Frequently Asked Questions What is ClearPoint Neuro's current short interest? Short interest is the volume of ClearPoint Neuro shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 744,900 shares of CLPT short. 2.88% of ClearPoint Neuro's shares are currently sold short. Learn More on ClearPoint Neuro's current short interest. What is a good short interest ratio for ClearPoint Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLPT shares currently have a short interest ratio of 3.0. Learn More on ClearPoint Neuro's short interest ratio. Which institutional investors are shorting ClearPoint Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ClearPoint Neuro: Group One Trading LLC, Citadel Advisors LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ClearPoint Neuro? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.88% of ClearPoint Neuro's floating shares are currently sold short. Is ClearPoint Neuro's short interest increasing or decreasing? ClearPoint Neuro saw a increase in short interest in March. As of March 15th, there was short interest totaling 744,900 shares, an increase of 2.8% from the previous total of 724,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ClearPoint Neuro's short interest compare to its competitors? 2.88% of ClearPoint Neuro's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to ClearPoint Neuro: Cadre Holdings, Inc. (8.09%), Tandem Diabetes Care, Inc. (10.94%), InMode Ltd. (9.79%), Liquidia Co. (20.40%), BioLife Solutions, Inc. (7.65%), MiMedx Group, Inc. (2.86%), Establishment Labs Holdings Inc. (22.95%), Paragon 28, Inc. (2.61%), RxSight, Inc. (7.40%), Artivion, Inc. (8.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short ClearPoint Neuro stock? Short selling CLPT is an investing strategy that aims to generate trading profit from ClearPoint Neuro as its price is falling. CLPT shares are trading down $0.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ClearPoint Neuro? A short squeeze for ClearPoint Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPT, which in turn drives the price of the stock up even further. How often is ClearPoint Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPT, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Cadre Short Squeeze Tandem Diabetes Care Short Squeeze InMode Short Squeeze Liquidia Short Squeeze BioLife Solutions Short Squeeze MiMedx Group Short Squeeze Establishment Labs Short Squeeze Paragon 28 Short Squeeze RxSight Short Squeeze Artivion Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLPT) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLPT Stock Free CLPT Stock Alerts